US OptionsDetailed Quotes
ARDX241220C11000
- 0.00
- 0.000.00%
15min DelayClose Nov 22 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest11.00Strike Price0.00Turnover0.00%IV107.16%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.62Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ardelyx Stock Discussion
Sign in to post a comment
$Ardelyx (ARDX.US)$ There's nothing to worry about folks, just buy the dip
4
$Ardelyx (ARDX.US)$
The price drop was caused by a perfect storm of negative factors. In pre-market trading hours, one or more whales received word of the court decision ahead of most other investors: probably through Barchart and premium terminal services (or boots-on-the-ground observers). If you look at the volume chart, most of the trade volume occurred very early, and the daily trading volume is well over 4x the daily average.
Because there was this big ...
The price drop was caused by a perfect storm of negative factors. In pre-market trading hours, one or more whales received word of the court decision ahead of most other investors: probably through Barchart and premium terminal services (or boots-on-the-ground observers). If you look at the volume chart, most of the trade volume occurred very early, and the daily trading volume is well over 4x the daily average.
Because there was this big ...
6
$Ardelyx (ARDX.US)$
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
$Ardelyx (ARDX.US)$ what is going on
1
2
$Ardelyx (ARDX.US)$ ardx out for a rip today
$Ardelyx (ARDX.US)$ resurrected
1
$Ardelyx (ARDX.US)$ Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting
6 MINUTES AGO, 4:05 PM EDT
VIA GLOBENEWSWIRE
Ninety percent of survey participants reported "some" or "significant" negative impact of IBS-C on their life
Survey results presented in two poster presentations
6 MINUTES AGO, 4:05 PM EDT
VIA GLOBENEWSWIRE
Ninety percent of survey participants reported "some" or "significant" negative impact of IBS-C on their life
Survey results presented in two poster presentations
1
3
️
2
$Ardelyx (ARDX.US)$ this one's gonna boom soon you'll don't even know
1
No comment yet
Tom’s Jerry : Why do you have so much faith in this stock? Is there any advantage that we don't know about?
Richard Fain Fan OP Tom’s Jerry : Yeah. An over reaction by pussy retail investors, we’ll take it to the Supreme Court. fundamentals still there. Top drug not even priced in. Trading at only 2x multiples. Big money gobbling this up.
交流道的小赢熊 : Yes. Long term investors of ARDX will know this move downwards is nothing. We have been through worse with it than this.
Buy and be patient. You'll be rewarded in future.
Richard Fain Fan OP 交流道的小赢熊 : Exactly, I know the company very well and what I'm holding